Dr. Yarchoan on Unique Characteristics of Fibrolamellar Carcinoma

Video

Mark Yarchoan, MD, discusses unique characteristics of fibrolamellar carcinoma.

Mark Yarchoan, MD, assistant professor of oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, discusses unique characteristics of fibrolamellar carcinoma (FC).

FC is a distinct type of liver cancer, Yarchoan says. Unlike hepatocellular carcinoma (HCC), which typically occurs in older patients who have underlying liver disease like cirrhosis, FC tends to occur in younger patients without underlying liver disease.

Additionally, the disease is characterized by the presence of DNAJB1-PRKACA oncogenic fusions or rearrangements, which are unique driver abnormalities for cancer growth, Yarchoan says. As such, FC is epidemiological and genetically distinct from HCC, Yarchoan concludes.

Related Videos
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Vikram M. Narayan, MD, assistant professor, Department of Urology, Emory University School of Medicine, Winship Cancer Institute; director, Urologic Oncology, Grady Memorial Hospital
Stephen V. Liu, MD
S. Vincent Rajkumar, MD
Pashtoon Murtaza Kasi, MD, MS
Naseema Gangat, MBBS
Samilia Obeng-Gyasi, MD, MPH,
Kian-Huat Lim, MD, PhD
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Muhamed Baljevic, MD